A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors.

Sharma S, Beck J, Mita M, Paul S, Woo MM, Squier M, Gadbaw B, Prince HM. A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors. Invest New Drugs. 2013 Aug; 31(4):974-85.

View in: PubMed